Drug: infliximab, recombinant Quarter: 2016Q3
Total Records: 276 Number of Pages: 14
| DRUGNAME | PT | EventCount |
|---|---|---|
| INFLIXIMAB, RECOMBINANT | Diffuse large B-cell lymphoma | 1 |
| INFLIXIMAB, RECOMBINANT | Drug dose omission | 1 |
| INFLIXIMAB, RECOMBINANT | Drug eruption | 1 |
| INFLIXIMAB, RECOMBINANT | Drug ineffective for unapproved indication | 1 |
| INFLIXIMAB, RECOMBINANT | Dry skin | 1 |
| INFLIXIMAB, RECOMBINANT | Dysplasia | 1 |
| INFLIXIMAB, RECOMBINANT | Eczema | 1 |
| INFLIXIMAB, RECOMBINANT | Empyema | 1 |
| INFLIXIMAB, RECOMBINANT | Encephalopathy | 1 |
| INFLIXIMAB, RECOMBINANT | Enteritis infectious | 1 |
| INFLIXIMAB, RECOMBINANT | Escherichia infection | 1 |
| INFLIXIMAB, RECOMBINANT | Exophthalmos | 1 |
| INFLIXIMAB, RECOMBINANT | Fungal infection | 1 |
| INFLIXIMAB, RECOMBINANT | Fusarium infection | 1 |
| INFLIXIMAB, RECOMBINANT | Gastrointestinal motility disorder | 1 |
| INFLIXIMAB, RECOMBINANT | Groin abscess | 1 |
| INFLIXIMAB, RECOMBINANT | Haemorrhage | 1 |
| INFLIXIMAB, RECOMBINANT | Headache | 1 |
| INFLIXIMAB, RECOMBINANT | Hepatic enzyme increased | 1 |
| INFLIXIMAB, RECOMBINANT | Hepatitis B | 1 |
Total Records: 276 Number of Pages: 14